Δευτέρα 29 Αυγούστου 2016

Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: A 156-week longitudinal observational study in daily practice

Journal of Bone and Mineral Metabolism

from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2bLusv8

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις